Terms: = Liver cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Treatment
532 results:
1. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
[TBL] [Abstract] [Full Text] [Related]
2. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via stat3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract] [Full Text] [Related]
3. Exosomal lncRNA HEIH, an essential communicator for hepatocellular carcinoma cells and macrophage M2 polarization through the miR-98-5p/stat3 axis.
Ai JH; Wen YZ; Dai SJ; Zhang LD; Huang ZJ; Shi J
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23686. PubMed ID: 38549433
[TBL] [Abstract] [Full Text] [Related]
4. Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/stat3 signal pathway.
Shi X; Lai Y; Liu W; Zhang X; Cang Y
Biochem Biophys Res Commun; 2024 Apr; 706():149758. PubMed ID: 38484571
[TBL] [Abstract] [Full Text] [Related]
5. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
6. Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma.
He M; Liu Y; Chen S; Deng H; Feng C; Qiao S; Chen Q; Hu Y; Chen H; Wang X; Jiang X; Xia X; Zhao M; Lyu N
Nat Commun; 2024 Feb; 15(1):1754. PubMed ID: 38409200
[TBL] [Abstract] [Full Text] [Related]
7. Interferon-α induces differentiation of cancer stem cells and immunosuppression in hepatocellular carcinoma by upregulating CXCL8 secretion.
Ma YT; Zheng L; Zhao CW; Zhang Y; Xu XW; Wang XY; Niu GP; Man ZS; Gu F; Chen YQ
Cytokine; 2024 May; 177():156555. PubMed ID: 38387232
[TBL] [Abstract] [Full Text] [Related]
8. Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma.
Yu H; Sun F; Xu Y; Yang H; Tian C; Li C; Kang Y; Hao L; Yang P
Hum Gene Ther; 2024 Mar; 35(5-6):177-191. PubMed ID: 38386514
[TBL] [Abstract] [Full Text] [Related]
9. Targeting C21orf58 is a Novel treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/stat3 Complex.
Jiang H; Wang Y; Wen D; Yu R; Esa SS; Lv K; Feng Q; Liu J; Li F; He L; Di X; Zhang S
Adv Sci (Weinh); 2024 Apr; 11(15):e2306623. PubMed ID: 38342622
[TBL] [Abstract] [Full Text] [Related]
10. Cepharanthine suppresses proliferation and metastasis and enhances apoptosis by regulating JAK2/stat3 pathway in hepatocellular carcinoma.
Liang Y; Li J; Xu H; Pang M; Hu C; Weng X; Xie W
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):94-100. PubMed ID: 38279472
[TBL] [Abstract] [Full Text] [Related]
11. Regucalcin downregulation in human cancer.
Ghanem NZ; Yamaguchi M
Life Sci; 2024 Mar; 340():122448. PubMed ID: 38246519
[TBL] [Abstract] [Full Text] [Related]
12. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21.
Sui Y; Liu Q; Xu C; Ganesan K; Ye Z; Li Y; Wu J; Du B; Gao F; Song C; Chen J
Cell Death Dis; 2024 Jan; 15(1):67. PubMed ID: 38238320
[TBL] [Abstract] [Full Text] [Related]
13. Astaxanthin Augmented the Anti-Hepatocellular Carcinoma Efficacy of Sorafenib Through the Inhibition of the JAK2/stat3 Signaling Pathway and Mitigation of Hypoxia within the Tumor Microenvironment.
Ren P; Tang Q; He X; Xu J; Wang Y; Xue C
Mol Nutr Food Res; 2024 Jan; 68(2):e2300569. PubMed ID: 38059808
[TBL] [Abstract] [Full Text] [Related]
14. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/stat3 signaling pathway.
Hu J; Chen K; Hong F; Gao G; Dai X; Yin H
Cancer Gene Ther; 2024 Feb; 31(2):228-236. PubMed ID: 38030810
[TBL] [Abstract] [Full Text] [Related]
15. Metformin reduces hepatocarcinogenesis by inducing downregulation of Cyp26a1 and CD8
He W; Wang X; Chen M; Li C; Chen W; Pan L; Cui Y; Yu Z; Wu G; Yang Y; Xu M; Dong Z; Ma K; Wang J; He Z
Clin Transl Med; 2023 Nov; 13(11):e1465. PubMed ID: 37997519
[TBL] [Abstract] [Full Text] [Related]
16. m
Wei H; Yang J; Lu R; Huang Y; Huang Z; Huang L; Zeng M; Wei Y; Xu Z; Li W; Pu J
Sci Rep; 2023 Nov; 13(1):19124. PubMed ID: 37926706
[TBL] [Abstract] [Full Text] [Related]
17. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
Sohel M
Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
[TBL] [Abstract] [Full Text] [Related]
18. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
[TBL] [Abstract] [Full Text] [Related]
19. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
20. Advances in investigating microcystin-induced liver toxicity and underlying mechanisms.
Li T; Fan X; Cai M; Jiang Y; Wang Y; He P; Ni J; Mo A; Peng C; Liu J
Sci Total Environ; 2023 Dec; 905():167167. PubMed ID: 37730048
[TBL] [Abstract] [Full Text] [Related]
[Next]
